Abstract
Background
This study aimed to clarify the clinical significance of lymph node micrometastasis in ampullary carcinoma.
Materials and Methods
Pancreaticoduodenectomy with regional lymphadenectomy was performed for 50 consecutive patients with ampullary carcinoma. A total of 1,283 regional lymph nodes (median, 25 per patient) were examined histologically for metastases. Overt metastasis was defined as metastasis detected during routine histologic examination with hematoxylin and eosin. Micrometastasis was defined as metastasis first detected by immunohistochemistry with an antibody against cytokeratins 7 and 8. The median follow-up period was 119 months after resection.
Results
Overt metastasis was positive in 90 lymph nodes from 27 patients. Micrometastasis was positive in 33 lymph nodes from 12 patients, all of whom also had overt nodal metastases. Patients with nodal micrometastasis had a larger number of lymph nodes with overt metastasis (median, 3.5) than those without (median, 0; P < 0.001). Overt metastasis to distant nodes (superior mesenteric nodes, para-aortic nodes) was more frequent (P = 0.001 and P = 0.038, respectively) in patients with nodal micrometastasis. Nodal micrometastasis was found to be a strong independent prognostic factor on univariate (P < 0.0001) and multivariate (relative risk, 5.085; P = 0.007) analyses. From among the 27 patients with overt nodal metastasis, the outcome after resection was significantly worse in the patients with nodal micrometastasis (median survival time of 11 months) than in those without (median survival time of 63 months; P = 0.0009).
Conclusions
Immunohistochemically detected lymph node micrometastasis indicates intensive lymphatic spread, and thus adversely affects the survival of patients with ampullary carcinoma.
Similar content being viewed by others
References
Delcore R Jr, Connor CS, Thomas JH, et al. Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg 1989;158:593–597
Shutze WP, Sack J, Aldrete JS. Long-term follow-up of 24 patients undergoing radical resection for ampullary carcinoma, 1953–1988. Cancer 1990;66:1717–1720
Monson JR, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991;126:353–357
Shirai Y, Tsukada K, Ohtani T, et al. Carcinoma of the ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 1996;61:190–194
Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampullary carcinoma of Vater. A 28-year experience. Ann Surg 1997;225:590–600
Lee JH, Whittington R, Williams NN, et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol 2000;47:945–953
Wells CA, Heryet A, Brochier J, et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50:193–197
Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase–polymerase chain reaction. Cancer 1994;74:1595–1600
Hayashi N, Ito I, Nagase H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res 1994;54:3853–3856
Maehara Y, Oshino T, Endo K, et al. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397–402
Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188–1194
McGuckin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88–95
Lara J, Young S, Velilla R, et al. The relevance of occult axillary metastasis in ductal carcinoma in situ. Cancer 2003;98:2105–2113
Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected non-small cell lung cancer impact on recurrence and survival. Ann Surg 2002;235:133–139
Ohta Y, Oda M, Wu J, et al. Can the tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastases. J Thorac Cardiovasc Surg 2001;122:900–906
Glickmam JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769–778
Natsugoe A, Mueller J, Stein HJ, et al. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer 1998;83:858–866
Ishida K, Katsuyama T, Sugiyama A, et al. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069–1076
Cai J, Ikeguchi M, Maeta M, et al. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery 2000;127:32–39
Sasaki M, Watanabe H, Jass JR, et al. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras. Histopathology 1998;32:199–208
Oberg A, Stenling R, Travelin B, et al. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244–1249
Yokoyama N, Shirai Y, Hatakeyama K. Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody. Cancer 1999;85:1465–1469
Nagakura S, Shirai Y, Yokoyama N, et al. Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery 2001;129:704–713
Tojima Y, Nagino M, Ebata T, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 2003;237:201–207
Shirai Y, Ohtani T, Tsukada K, et al. Patterns of lymphatic spread of carcinoma of the ampulla of Vater. Br J Surg 1997;84:1012–1016
Greene FL, Page DL, Fleming ID, editors. (2002) American Joint Committee on Cancer (AJCC) Staging Manual 6th edn. Springer, Berlin Heidelberg New York, pp 151–156
Dimandopoulos GTH, Meissner WA. (1985) Neoplasia. In: Kissane JM, editor. Anderson’s Pathology, vol 1, 8th edn, Mosby, St. Louis, pp 514–559
Yamaguchi K, Nagai E, Ueki T, et al. Carcinoma of the ampulla of Vater. Aust N Z J Surg 1993;63:256–262
Todoroki T, Koike K, Yukio M, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003;10:1176–1183
Acknowledgements
This work was supported in part by the Grant-in-Aid for Scientific Research #16591301 (T.W., Y.S., and N.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakata, E., Shirai, Y., Yokoyama, N. et al. Clinical Significance of Lymph Node Micrometastasis in Ampullary Carcinoma. World J. Surg. 30, 985–991 (2006). https://doi.org/10.1007/s00268-005-7985-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-7985-8